Abstract:This study identifies a natural compound with potent HIV integrase strand transfer inhibitory (INSTI) activity. A pharmacophore model, validated by molecular docking, MD simulations, and MM‐PBSA analysis, highlights stable interactions with key HIV‐1 integrase residues. ADMET profiling and in vitro assays confirm its efficacy, marking it as a promising candidate for advancing antiretroviral therapies. Background AIDS is a highly prevalent and life‐threatening global epidemic that severely compromises the host's immune system, increasing vulnerability to opportunistic diseases. The absence of definitive curative drugs emphasizes the importance and necessity of discovering novel anti‐HIV agents. Objective This study aims to discover a natural molecular entity that acts as an Integrase strand transfer inhibitor (INSTI) with enhanced potency against HIV. Methods A ligand‐based pharmacophore model was developed for 4 FDA‐approved INSTIs, with the potential for treating HIV‐1. AutoDock facilitated molecular docking and free energy calculation to discern IN activity. Subsequently, MD simulations assessed interaction stability. ADMET analysis preceded an in vitro anti‐HIV strand transfer assay. Results The generated model revealed a specific interaction involving Mg2+ ion chelation. Crucial residues of HIV‐1 IN and their respective free‐binding energies were identified. The lead compound exhibited superior in silico characteristics which were substantiated by 100 ns MD simulations and MM‐PBSA analysis. Additionally, the in vitro assay demonstrated potent inhibition with the lowest IC50, forming strong molecular interactions with IN. Conclusion These findings showed valuable insights for the strategic development of new antiretroviral treatments (ART), paving the path for the development of natural therapeutic agents for HIV treatment.

Molecular dynamics study of carbon nanotube as a potential dual-functional inhibitor of HIV-1 integrase.

Structure-based Design of Carbon Nanotubes As HIV-1 Protease Inhibitors: Atomistic and Coarse-Grained Simulations.

Research Progress of HIV-1 Integrase and Its Inhibitors

Nano-engineering Thermal Transport Performance of Carbon Nanotube Networks with Polymer Intercalation: a Molecular Dynamics Study.

Computational identification and analysis of CNP0269688 as a natural product inhibitor disrupting the interaction between the HIV matrix domain and tRNA

Study on the molecular mechanism of inhibiting HIV-1 integrase by EBR28 peptide via molecular modeling approach

Selective Small Molecules Blocking HIV-1 Tat and Coactivator PCAF Association.

Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte.

Size-dependent Impact of CNTs on Dynamic Properties of Calmodulin.

Progress in Research on HIV-1 Integrase and Its Inhibitors

Prediction of the Binding Mode between the Small Peptide Inhibitor EBR28 with Integrase through Molecular Modeling Methods

Molecular design and evaluation of aza-polycyclic carbamoyl pyridones as HIV-1 integrase strand transfer inhibitors

Design, synthesis and biological evaluation of caffeoyl benzanilides as dual inhibitors of HIV integrase and CCR5

The Discovery of Indole-2-carboxylic Acid Derivatives as Novel HIV-1 Integrase Strand Transfer Inhibitors

Recent Progress in HIV-1 Inhibitors Targeting the Entrance Channel of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Binding Pocket

Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactions

Mechanisms of HIV-1 integrase resistance to dolutegravir and potent inhibition of drug-resistant variants

Identification of a Novel HIV‐1 Integrase Strand Transfer Inhibitor: A Synergistic Approach Combining Pharmacophore Modelling and In Vitro Assays

Modelling Carbon Nanotube Based Bio-Nano Systems: A Molecular Dynamics Study

Screening and identification of inhibitors on HIV-1 integrase

Dual targeting inhibitors for HIV-1 capsid and cyclophilin A: molecular docking, molecular dynamics, and quantum mechanics